Biomarker-based Prognostication

Biomarker-Based Prognostication is a clinical assessment approach that uses quantifiable biological markers to predict the future course of neurological outcomes, distinguished by its reliance on objective, measurable molecular, imaging, or electrophysiological indicators to inform disease progression, recovery potential, or risk of deterioration in neurologic disorders.

361

Publications

19.6K

Citations

3.4K

Authors

1.1K

Institutions

Publications per year

2017–2026

192

Authors

3.4K

  1. HZ
    Henrik Zetterberg

    University of Gothenburg, Sweden

    8 publications · 441 citations

    8

    h-index

  2. KB
    Kaj Blennow

    University of Gothenburg, Sweden

    7 publications · 409 citations

    7

    h-index

  3. JK
    Jens Kühle

    University Hospital of Basel, Switzerland

    5 publications · 314 citations

    5

    h-index

  4. AL
    Alberto Lleó

    Hospital de Sant Pau, Spain

    5 publications · 248 citations

    5

    h-index

  5. SL
    Sylvain Lehmann

    Inserm, France

    5 publications · 210 citations

    5

    h-index

1–5 of 3.4K

Venues

  1. PLoS ONE

    12 publications · 626 citations

    11

    h-index

  2. PubMed

    Repository · 8 publications · 192 citations

    8

    h-index

  3. Frontiers in Neurology

    6 publications · 145 citations

    6

    h-index

  4. The American Journal of Cardiology

    6 publications · 177 citations

    6

    h-index

  5. Scientific Reports

    6 publications · 257 citations

    6

    h-index

1–5